Bernard P. Murray - Concepedia

Author

Bernard P. Murray

Also Known As

B Murray, B P Murray, B. Murray, B. P. MURRAY, B. P. Murray, B.P. Murray, BERNARD P. MURRAY, Bernard Murray, Bernard P. Murray

101

Publications

Citations

H-Index

Concepts

All Affiliations

Gilead Sciences (United States)London Postgraduate Medical and Dental Education University of California, San Francisco Merck & Co., Inc., Rahway, NJ, USA (United States)Washington State University Spokane

About

Bernard P. Murray is an author at Gilead Sciences (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	22	971
2	Biochemistry	13	16	801
3	Natural Sciences	11	14	638
4	Health Sciences	4	4	229
5	Allergy	2	2	62

Bernard P. Murray

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib Paqui G. Través, Bernard P. Murray, Federico Campigotto, Annals of the Rheumatic Diseases	2021	307
Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat Eve‐Irene Lepist, Xuexiang Zhang, Hao Jia, Kidney International	2014	239
Pharmacokinetics and Pharmacodynamics of GS-9350: A Novel Pharmacokinetic Enhancer Without Anti-HIV Activity Anita Mathias, Polina German, Bernard P. Murray, Clinical Pharmacology & Therapeutics	2009	206
Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer Lianhong Xu, Hongtao Liu, Bernard P. Murray, ACS Medicinal Chemistry Letters Human Cyp3aPharmacotherapyAntiviral DrugChemical BiologyPharmaceutical Chemistry	2010	200
Cobicistat Boosts the Intestinal Absorption of Transport Substrates, Including HIV Protease Inhibitors and GS-7340, <i>In Vitro</i> Eve‐Irene Lepist, Truc K. Phan, Anupma Roy, Antimicrobial Agents and Chemotherapy Transporter InhibitionImmunologyPharmacotherapyDigestive TractTransport Substrates	2012	134
Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and human Robert J. Edwards, Bernard P. Murray, Stephen A. Murray, Carcinogenesis	1994	125
Discovery and Biological Evaluation of 5-Aryl-2-furfuramides, Potent and Selective Blockers of the Na<sub>v</sub>1.8 Sodium Channel with Efficacy in Models of Neuropathic and Inflammatory Pain Michael E. Kort, Irene Drizin, Robert J. Gregg, Journal of Medicinal Chemistry Pain DisordersPain MedicineNeuropathic PainMolecular PainPharmacotherapy	2008	83
Identification and location of .alpha.-helices in mammalian cytochromes P450 Robert J. Edwards, Bernard P. Murray, Alan R. Boobis, Biochemistry	1989	83
Characterization of Differential Tissue Abundance of Major Non-CYP Enzymes in Human Abdul Basit, Naveen K. Neradugomma, Christopher C. Wolford, Molecular Pharmaceutics PathologyRedox BiologyToxicological MechanismOxidative StressProtein Expression	2020	82
Orientation of cytochromes P450 in the endoplasmic reticulum Robert J. Edwards, Bernard P. Murray, Alison M. Singleton, Biochemistry	1991	75

Page 1